Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma

NCT03393936 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

66

Enrollment

INDUSTRY

Sponsor class

Stopped Adjustment of study strategy

Conditions

Renal Cell Carcinoma

Interventions

BIOLOGICAL: CCT301-38
BIOLOGICAL: CCT301-59

Sponsor

Shanghai PerHum Therapeutics Co., Ltd.

Collaborators

[object Object]